Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It ...
(UroToday.com) The 2025 ESMO annual meeting featured a kidney cancer session and a presentation by Dr. Camillo Guglielmo Porta discussing the final analysis of lenvatinib + pembrolizumab versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results